Anthropic, a U.S. artificial intelligence (AI) startup dubbed a rival to OpenAI, has unveiled an AI service specialized for life sciences research.
Anthropic said on the 20th (local time) that it launched Claude for Life Sciences, which provides researchers with specialized tools and techniques based on the company's advanced AI models. The service aims to support the entire process with AI technology, from the early stages of research through technology transfer and commercialization.
Claude for Life Sciences is Anthropic's first entry into the life sciences field. Anthropic said it added multiple "connector" features that link to scientific platforms based on its most capable AI model, Claude Sonnet 4.5, and introduced various "agent skills" that help improve task execution.
One of the connector features, BioRender, links Claude with vetted scientific diagrams, iKON, and templates, while PubMed allows access to millions of biomedical research papers and clinical study materials.
Agent skill tools include a "protocol generation" feature in which Claude drafts research protocols and standard operating procedures; a "bioinformatics and data analysis" feature that processes and analyzes genome data with Claude Code; and a feature that identifies relevant regulatory requirements and drafts documents for submission to authorities.
Eric Caldera-Abrams, head of life sciences at Anthropic, said in an interview with business outlet CNBC that "just as coding work is currently performed in Claude, we hope a significant portion of life sciences work worldwide will be carried out through Claude."